Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer
Liya Ding, Qiwei Wang, Antons Martincuks, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 1, pp. e005627-e005627
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 43
The balance of STING signaling orchestrates immunity in cancer
Klara Rasmussen Bollerup Lanng, Emil Leth Lauridsen, Martin R. Jakobsen
Nature Immunology (2024) Vol. 25, Iss. 7, pp. 1144-1157
Closed Access | Times Cited: 36
Novel tumor-associated macrophage populations and subpopulations by single cell RNA sequencing
Juanjuan Wang, Ningning Zhu, Lei Su, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 21
Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation
Zili Gu, Hao Yang, Timo Schomann, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 531-544
Open Access | Times Cited: 38
Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
Hao Yang, Zhong-Hao Ji, Hengzong Zhou, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 30
BRCAness, DNA gaps, and gain and loss of PARP inhibitor–induced synthetic lethality
Xin Li, Lee Zou
Journal of Clinical Investigation (2024) Vol. 134, Iss. 14
Open Access | Times Cited: 13
The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways
Dengxiong Li, Fanglin Shao, Qingxin Yu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access | Times Cited: 1
cGAS/STING signaling pathway in gynecological malignancies: From molecular mechanisms to therapeutic values
Danyang Zhang, Bingxue Zhang
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Regulation of cGAS-STING signalling in cancer: Approach for combination therapy
Hitesh Vasiyani, Bhumika Wadhwa, Rajesh Singh
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188896-188896
Closed Access | Times Cited: 20
Enhancing cancer treatment via “Zn2+ interference” with Zn-based nanomaterials
Yandong Wang, Fucheng Gao, Zhao Li, et al.
Coordination Chemistry Reviews (2023) Vol. 500, pp. 215535-215535
Closed Access | Times Cited: 18
The Role of Mitochondria in Mediation of Skeletal Muscle Repair
Stephen E. Alway, Hector G. Paez, Christopher R. Pitzer
Muscles (2023) Vol. 2, Iss. 2, pp. 119-163
Open Access | Times Cited: 15
Cancer Stem Cells and the Tumor Microenvironment in Tumor Drug Resistance
Qiuzhi Gao, Yixiang Zhan, Li Sun, et al.
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 7, pp. 2141-2154
Closed Access | Times Cited: 15
Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancer
Antons Martincuks, Chunyan Zhang, Theresa Austria, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 4, pp. e007716-e007716
Open Access | Times Cited: 5
Macrophages: plastic participants in the diagnosis and treatment of head and neck squamous cell carcinoma
Lin Chen, Yidian Chu, Zheng Ye, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Col1A1 as a new decoder of clinical features and immune microenvironment in ovarian cancer
Xiao Xiao, Fangyi Long, Shaolan Yu, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
H2O2 self-supplying nanoparticles for chemodynamic and synergistic photodynamic therapy to augment cGAS/STING activation
Ai-Hong Zhang, Wei‐Chuang Kong, Xiaolei Zhang, et al.
Nanoscale (2025)
Closed Access
Exploration of ω-9MUFAs: mitigating effect on lipopolysaccharide-induced acute lung injury.
Qianqian Zheng, Gui Mei, Ping Cheng, et al.
European Journal of Pharmacology (2025), pp. 177396-177396
Closed Access
The interaction between IL-33 and TRIM28 in the regulation of macrophage polarization in an ST2-independent manner
Yuanxin Zhao, Huadan Xu, Qingqing Liu, et al.
International Immunopharmacology (2025) Vol. 152, pp. 114318-114318
Closed Access
DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS–STING signalling
Otto P.G. Wheeler, Leonie Unterholzner
Essays in Biochemistry (2023) Vol. 67, Iss. 6, pp. 905-918
Open Access | Times Cited: 12
Targeting PARP for the optimal immunotherapy efficiency in gynecologic malignancies
Tianye Li, Xinrun Wang, Shuang Qin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114712-114712
Open Access | Times Cited: 9
Targeting C21orf58 is a Novel Treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of JAK2/C21orf58/STAT3 Complex
Hao Jiang, Yang Wang, Doudou Wen, et al.
Advanced Science (2024) Vol. 11, Iss. 15
Open Access | Times Cited: 3
Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma
Lin Dong, Chao Liu, Haoyang Sun, et al.
Cancer Letters (2024) Vol. 593, pp. 216956-216956
Closed Access | Times Cited: 3
Daphnetin induces ferroptosis in ovarian cancer by inhibiting NAD(P)H:Quinone oxidoreductase 1 (NQO1)
Ning Ma, Mengwen Zhang, Jianqiang Hu, et al.
Phytomedicine (2024) Vol. 132, pp. 155876-155876
Open Access | Times Cited: 3
Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer
Noor Shakfa, Deyang Li, Gwenaëlle Conseil, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 4, pp. e006170-e006170
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top